Lumos Pharma, Inc.

LUMO · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$35,078$56,007$94,809$98,679
Short-Term Investments$999$11,352$0$0
Receivables$210$223$128$26,264
Inventory$0$0$0$0
Other Curr. Assets$3,748$4,427$4,740$3,506
Total Curr. Assets$40,035$72,009$99,677$128,449
Property Plant & Equip (Net)$603$283$635$584
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0-$283-$635-$584
Total NC Assets$603$283$635$584
Other Assets$0$0$0$0
Total Assets$40,638$72,292$100,312$129,033
Liabilities
Payables$890$275$612$244
Short-Term Debt$564$466$704$638
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,576$5,967$3,814$5,579
Total Curr. Liab.$7,030$6,708$5,130$6,461
LT Debt$303$0$205$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,000$0$6,000$0
Total NC Liab.$6,303$6,000$6,205$6,000
Other Liabilities$0$0$0$0
Cap. Leases$585$233$557$319
Total Liabilities$13,333$12,708$11,335$12,461
Equity
Pref Stock$0$0$0$0
Common Stock$81$82$83$83
Retained Earnings-$161,517-$127,483-$96,421-$65,991
AOCI-$0-$9$0$0
Other Equity$188,741$186,994$185,315$182,480
Total Equity$27,305$59,584$88,977$116,572
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$40,638$72,292$100,312$129,033
Net Debt-$34,211-$55,541-$93,900-$98,041